Method and apparatus for antigen retrieval process
View Patent ↗The invention provides a method for antigen retrieval of a formaldehyde-fixed tissue sample comprising incubating a formaldehyde-fixed tissue sample in a first antigen retrieval solution at a temperature of greater than 90° C., transferring the tissue sample to a second antigen retrieval solution, and incubating the tissue sample in the second antigen retrieval solution at a temperature of greater than 90° C. The invention also provides a kit and sample delivery device for carrying out the method.
1. A method of antigen retrieval of a formaldehyde-fixed tissue sample comprising the steps of:
incubating the formaldehyde-fixed tissue sample in a first antigen retrieval solution at a temperature of greater than 90° C.;
transferring the formaldehyde-fixed tissue sample to a second antigen retrieval solution;
incubating the formaldehyde-fixed tissue sample in the second antigen retrieval solution at a temperature of greater than 90° C.; and
wherein the first antigen retrieval solution comprises a buffer solution having a pH range of between about 5 and about 7 and the second antigen retrieval solution comprises a buffer solution having a pH range of between about 7.5 and about 11; or
the first antigen retrieval solution comprises a buffer solution having a pH range of between about 7.5 and about 11 and the second antigen retrieval solution comprises a buffer solution having a pH range of between about 5 and about 7.
2. The method of claim 1 wherein the buffer solution having a pH range between about 5 and about 7 comprises citric acid, potassium dihydrogen phosphate, boric acid, diethyl barbituric acid, piperazine-N,N′-bis(2-ethanesulfonic acid), dimethylarsinic acid, 2-(N-morpholino)ethanesulfonic acid, or a combination thereof.
3. The method of claim 2 , wherein the buffer solution having a pH range of between about 5 and about 7 comprises citric acid.
4. The method of claim 1 , wherein the buffer solution having a pH range of between about 7.5 and about 11 comprises tris(hydroxymethyl)methylamine (TRIS), 2-(N-morpholino)ethanesulfonic acid (TAPS), N,N-bis(2-hydroxyethyl)glycine(Bicine), N-tris(hydroxymethyl)methylglycine (Tricine), 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES), 2-{[tris(hydroxymethyl)methyl]amino }ethanesulfonic acid (TES), or a combination thereof.
5. The method of claim 4 , wherein the buffer solution having a pH range of between about 7.5 and about 11 comprises TRIS.
6. The method of claim 1 , wherein the formaldehyde- fixed tissue sample is embedded in paraffm.
7. The method of claim 1 , wherein the formaldehyde- fixed tissue sample is a sectional portion of an organ or tissue, body fluid, a tissue or microarray.
8. The method of claim 1 , wherein the incubating steps with the first antigen retrieval solution and the second antigen retrieval solution comprises incubation in a heating device for a period of greater than ten minutes.
9. The method of claim 8 wherein the heating device is a pressure cooker, autoclaving, water bath, hot plate, microwave, steam heating, or combination thereof.
10. The method of claim 1 further comprising the step of immunostaining of antigens.
11. The method of claim 10 wherein the immunostaining comprises sequential immunoperoxidase labeling and erasing.
12. The method of claim 1 wherein the formaldehyde-fixed tissue sample undergoes fluorescent in situ hybridization (FISH) or chromagenic in situ hybridization (CISH) analysis.